Orexigen Therapeutics Receives $70,000,000 New Financing

  • Feed Type
  • Date
    7/23/2009
  • Company Name
    Orexigen Therapeutics
  • Mailing Address
    3344 N. Torrey Pines Court La Jolla, CA 92037
  • Company Description
    OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.
  • Website
    http://www.orexigen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $70,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.